Heartflow, Inc. Financing Cash Flow
Heartflow, Inc. (HTFL) reported Financing Cash Flow of $8.21 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-13
- Heartflow, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $2.05M.
- Heartflow, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $6.16M, a 91.56% decline year-over-year.
- Heartflow, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was -$50.00K, a 105.88% decline year-over-year.
- Heartflow, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $214.94M, a 21766.12% increase year-over-year.
- Heartflow, Inc. net cash provided by (used in) financing activities for fiscal 2025 was $286.04M, a 12686.90% increase from fiscal 2024.
- Heartflow, Inc. net cash provided by (used in) financing activities for fiscal 2024 was $2.24M, a 98.68% decline from fiscal 2023.
- Heartflow, Inc. net cash provided by (used in) financing activities for fiscal 2023 was $169.32M.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $8.21M 10-Q · filed 2026-08-13 | $8.16M derived: sum of 3 quarters · filed 2026-08-13 | $223.10M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $6.16M 10-Q · filed 2026-05-14 | $6.11M derived: sum of 2 quarters · filed 2026-05-14 | $221.05M derived: sum of 3 quarters · filed 2026-05-14 | $219.28M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | -$50.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $214.89M derived: sum of 2 quarters · filed 2026-03-18 | $213.12M derived: sum of 3 quarters · filed 2026-08-13 | $286.04M 10-K · filed 2026-03-18 |
| 2025-09-30 | $214.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $213.17M derived: sum of 2 quarters · filed 2026-08-13 | $286.09M 10-Q · filed 2025-11-12 | $286.94M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | -$1.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $71.15M 10-Q · filed 2026-08-13 | $72.00M derived: sum of 3 quarters · filed 2026-08-13 | $72.98M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $72.92M 10-Q · filed 2026-05-14 | $73.77M derived: sum of 2 quarters · filed 2026-05-14 | $74.76M derived: sum of 3 quarters · filed 2026-05-14 | |
| 2024-12-31 | $851.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $1.83M derived: sum of 2 quarters · filed 2026-03-18 | $2.24M 10-K · filed 2026-03-18 | |
| 2024-09-30 | $983.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $1.39M 10-Q · filed 2025-11-12 | ||
| 2024-06-30 | $403.00K 10-Q · filed 2025-09-19 | |||
| 2023-12-31 | $169.32M 10-K · filed 2026-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |